Three considerations before advising 5-α-reductase inhibitors for chemoprevention

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalJournal of Clinical Oncology
Volume27
Issue number20
DOIs
StatePublished - Jul 10 2009

Fingerprint

5-alpha Reductase Inhibitors
3-Oxo-5-alpha-Steroid 4-Dehydrogenase
Medical Oncology
Medical Societies
Chemoprevention
Enzyme Inhibitors
Prostatic Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Three considerations before advising 5-α-reductase inhibitors for chemoprevention. / Walsh, Patrick.

In: Journal of Clinical Oncology, Vol. 27, No. 20, 10.07.2009.

Research output: Contribution to journalArticle

@article{7848e978e6634868b03ff3ec2053c85a,
title = "Three considerations before advising 5-α-reductase inhibitors for chemoprevention",
author = "Patrick Walsh",
year = "2009",
month = "7",
day = "10",
doi = "10.1200/JCO.2009.22.9070",
language = "English (US)",
volume = "27",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "20",

}

TY - JOUR

T1 - Three considerations before advising 5-α-reductase inhibitors for chemoprevention

AU - Walsh, Patrick

PY - 2009/7/10

Y1 - 2009/7/10

UR - http://www.scopus.com/inward/record.url?scp=70249126559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249126559&partnerID=8YFLogxK

U2 - 10.1200/JCO.2009.22.9070

DO - 10.1200/JCO.2009.22.9070

M3 - Article

C2 - 19487370

AN - SCOPUS:70249126559

VL - 27

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 20

ER -